» Articles » PMID: 24793688

Major Complications After Lung Microwave Ablation: a Single-center Experience on 204 Sessions

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2014 May 6
PMID 24793688
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study is to retrospectively evaluate the incidence of and risk factors for major complications after microwave ablation (MWA) of lung tumors.

Methods: From January 2011 to May 2013 in 184 consecutive patients (67 women and 117 men; mean age, 61.5 years; range, 19 to 85 years), 204 sessions of MWA were performed on 253 lung tumor lesions. Records were reviewed to evaluate prevalence of major complications and risk factors, which were analyzed using univariate and multivariate analyses.

Results: Major complications developed after 42 sessions (20.6%), including 32 cases (15.7%) of pneumothorax requiring chest tube placement which that were associated with emphysema (p=0.001); 6 cases (2.9%) of pleural effusions requiring chest tube placement, which were associated with a distance of less than 1 cm from chest wall to target tumor (p=0.014); 6 cases (2.9%) of pneumonia which that were associated with target tumor maximal diameter (p=0.040); number of pleural punctures (p=0.001) and ablation time (p=0.006); and 1 case (0.5%) of pulmonary abscess. Two cases (1.0%) of the large pneumothorax occurred at the same time with extensive subcutaneous emphysema, including 1 case (0.5%) caused by bronchopleural fistula. Death related to the procedures occurred after 1 session (0.5%).

Conclusions: As a relatively practical and safe modality, lung tumor MWA can induce serious complications. Enough attention should be paid to patients with emphysema, subpleural, or large target tumor, but the indications for lung MWA need not be limited as most major complications were easily managed.

Citing Articles

Microwave ablation permits an effective and safe treatment for lung metastasis of parathyroid carcinoma: A Retrospective Single-Center Study.

Chen Y, Song A, Wang Z, Kou L, Jiang Y, Li M Endocrine. 2025; .

PMID: 39987547 DOI: 10.1007/s12020-025-04201-2.


Improving Outcomes of CT-Guided Malignant Lung Lesion Microwave Ablation by Tract Sealing Using Venous Blood Clot.

Macionis A, Maziliauskiene G, Dubeikaite R, Vajauskas D, Adukauskiene D, Nedzelskiene I Diagnostics (Basel). 2024; 14(23).

PMID: 39682539 PMC: 11640691. DOI: 10.3390/diagnostics14232631.


Microwave ablation for high-risk pulmonary nodules in patients infected with the Omicron variant of Sars-Cov-2 within 3 months: a retrospective analysis of safety and efficacy.

Chen Y, Li Y, Meng H, Li C, Kong F Front Oncol. 2024; 14:1445245.

PMID: 39479014 PMC: 11523245. DOI: 10.3389/fonc.2024.1445245.


Transpulmonary chemoembolization and microwave ablation for recurrent or advanced non-small cell Lung Cancer.

Vogl T, Chen K, Li H, Fouad M, Afraz Z, Adwan H Sci Rep. 2024; 14(1):25491.

PMID: 39462003 PMC: 11513032. DOI: 10.1038/s41598-024-76323-y.


Risk prediction model for pneumothorax or pleural effusion after microwave ablation in patients with lung malignancy.

Wang Z, Liu Y, Cao X, Liu M, Wang L, Zhong L Heliyon. 2024; 10(19):e38422.

PMID: 39430441 PMC: 11489138. DOI: 10.1016/j.heliyon.2024.e38422.